This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • PARAGON: Phase II study of aromatase inhibitors in...
Clinical trial

PARAGON: Phase II study of aromatase inhibitors in women with potentially hormone responsive recurrent/metastatic gynaecological neoplasms

Read time: 1 mins
Last updated:23rd Aug 2011
The principal objective of the study is clinical benefit rate determined by the proportion of patients experiencing either stable disease or response within 3 months of commencing treatment.
Category Value
Study start date 2011-08-23

View full details